The National Institutes of Health (NIH) reported that chronic inflammation in the gut can leave lasting molecular changes in stem cells, increasing colorectal cancer risk, based on an NIH-funded study conducted by researchers at the Broad Institute of MIT and Harvard. The findings, published in 2026, show that these changes persist long after inflammation ends, with implications for cancer risk assessment and future treatment development.
Chronic inflammation has long been associated with cancer risk, but the mechanisms linking repeated tissue damage to long-term disease progression have remained unclear. The NIH-funded study provides new insight into how cellular memory may influence cancer development, particularly in the colon.
NIH study reveals link between inflammation and cancer risk
Researchers funded by the National Institutes of Health (NIH) conducted experiments simulating chronic colitis in mice to examine how repeated inflammation affects the colon. According to the National Cancer Institute (NCI), part of NIH, the study aimed to identify biological pathways that may increase colorectal cancer risk following inflammatory damage.
Meanwhile, the study analysed more than 52,000 individual cells, allowing researchers to observe changes during both active inflammation and recovery. These observations showed that inflammation triggered measurable shifts in cellular behaviour, which persisted after the initial damage had resolved.
Research overview and study scope
The research used animal models and organoid systems derived from injured tissue to track cellular responses over time. According to NIH-supported findings, this approach enabled scientists to observe how inflammation influenced gene expression and long-term cellular adaptation.
Additionally, the study focused on epigenetic changes, which are chemical modifications affecting how genes are expressed without altering DNA sequences. These mechanisms were identified as central to understanding how inflammation leaves lasting effects on gut cells.
Lasting changes in gut stem cells identified
The study found that chronic inflammation altered colonic stem cells in a way that persisted for more than 100 days after inflammation ceased. According to NIH-funded researchers, these changes were passed on as cells divided, indicating a heritable cellular memory.
However, while epigenetic flexibility allows cells to adapt to damage, the National Cancer Institute notes that these adaptations can have unintended consequences. In this case, the persistence of altered states increased susceptibility to tumour development over time.
Molecular mechanism involving AP-1
Researchers identified increased activity in AP-1 transcription factors as a central mechanism linking inflammation to cancer risk. According to the study authors, these proteins regulate cellular responses to stress and regeneration, and their heightened activity was sustained after recovery.
Additionally, when AP-1 activity was experimentally blocked, the increased tumour growth effect was no longer observed. This finding suggests a direct biological pathway through which chronic inflammation may influence cancer development.
Evidence of increased tumor growth risk
The study introduced tumour-inducing genes into mice that had previously experienced chronic colitis and compared them to healthy controls. According to NIH-supported data, tumour growth was significantly faster in the inflammation-exposed group.
Meanwhile, this comparative outcome provides measurable evidence linking prior inflammation to accelerated cancer progression. The findings indicate that the effects of inflammation extend beyond the active disease phase.
Comparative findings in study groups
| Indicator | Recent Movement | Context |
|---|---|---|
| Tumor growth rate | Increased in post-colitis models | NIH-funded study showed faster tumour development in previously inflamed mice |
| Cellular memory duration | Persisted over 100 days | Epigenetic changes remained after inflammation ended, according to study findings |
| AP-1 activity | Elevated in affected cells | Researchers identified AP-1 as a driver of stress-response and tumour growth pathways |
Implications for early detection and treatment
The findings suggest that long-term cellular changes could be used to assess cancer risk earlier. According to the National Cancer Institute, identifying these epigenetic markers may support improved monitoring of individuals with a history of chronic inflammation.
Additionally, researchers indicated that therapies targeting AP-1 activity could potentially reduce tumour growth. This approach may offer a pathway for developing treatments that interrupt the link between inflammation and cancer progression.
Potential future applications
- Risk assessment: NIH-supported research indicates epigenetic markers may help identify individuals with elevated colorectal cancer risk
- Therapeutic targeting: Study authors report that blocking AP-1 activity reduced tumour growth in experimental models
- Clinical translation: National Cancer Institute notes potential for applying findings to human disease monitoring if validated
Stakeholder Comments
Researcher perspectives
According to the National Cancer Institute, the study provides a clearer explanation of how repeated injury in the gut may influence long-term cancer risk. Officials noted that understanding these mechanisms could support earlier evaluation and intervention strategies.
Meanwhile, lead researchers at the Broad Institute stated that the persistence of inflammation-related changes demonstrates how recovery does not fully reset cellular risk. This highlights the need for further investigation into long-term effects following chronic disease.
In Conclusion
The NIH-funded study identifies a mechanism linking chronic gut inflammation to increased colorectal cancer risk through lasting epigenetic changes. By demonstrating how these alterations persist and influence tumour growth, the findings provide a clearer understanding of disease progression. The research may inform future diagnostic and therapeutic approaches if similar patterns are confirmed in human studies.
Sources: National Cancer Institute, National Institutes of Health.
Prepared by Ivan Alexander Golden, Founder of THX News, an independent news organization delivering timely insights from global official sources.
Research combines AI-assisted analysis with human-edited accuracy and context.
